Categories: Market Research

Filgrastim Biosimilars Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Filgrastim Biosimilars by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Filgrastim Biosimilars Market:

https://www.thebusinessresearchcompany.com/report/filgrastim-biosimilar-global-market-report

According to The Business Research Company’s Filgrastim Biosimilars, The filgrastim biosimilars market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%.  The  growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, government initiatives, increased healthcare expenditure, low cost of biosimilars, strong pipeline of drugs and increase in biopharmaceutical r&d expenditure.

The filgrastim biosimilars market size is expected to see rapid growth in the next few years. It will grow to $1.66 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%.  The growth in the forecast period can be attributed to aging population, increase in healthcare access,. Major trends in the forecast period include investing extensively in r&d activities for the development of effective and innovative biosimilars, production of biosimilars for neutropenia treatment to improve revenues and increasing their focus on m&a growth strategies.

The increasing prevalence of neutropenia is expected to propel the growth of the filgrastim biosimilar market going forward. Neutropenia refers to a condition where the body does not have enough neutrophils, which are an important type of white blood cell that fights infections. Filgrastim biosimilars work by stimulating the production of neutrophils in the bone marrow, which increases the neutrophil count and helps fight infections. For instance, in August 2022, according to the National Center for Biotechnology Information, a US-based database for biomedical literature, the prevalence of neutropenia was 0.38% among Mexican-Americans, 0.79% among whites, and 4.5% among black participants. Thus, the increasing prevalence of neutropenia is driving the growth of the filgrastim biosimilar market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=4016&type=smp

The filgrastim biosimilars market covered in this report is segmented –

1) By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing organization

2) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Major companies operating in the filgrastim biosimilar market are developing innovative products with advanced technologies such as recombinant DNA technology to produce biosimilars. Recombinant DNA technology is a process that involves the creation of hybrid or chimeric DNA by inserting a foreign sequence into the DNA of an organism. For instance, in May 2023,  Amneal Pharmaceuticals, a US-based pharmaceutical company launched FYLNETRA (pegfilgrastim-pbbk), a biosimilar to Amgen’s NEULASTA, in the United States indicated for the treatment and prevention of febrile neutropenia. It promotes the expansion and specialization of neutrophils originating from dedicated precursor cells, triggers their maturation, and improves the viability and efficiency of fully developed neutrophils, leading to dosage-dependent rises in neutrophil counts. The launch of Fylnetra contributes to the next wave of affordable medicines and drives access across patients, providers, and payors.

The filgrastim biosimilars market report table of contents includes:

 

  1. Executive Summary
  2. Filgrastim Biosimilars Market Characteristics
  3. Filgrastim Biosimilars Market Trends And Strategies
  4. Filgrastim Biosimilars Market – Macro Economic Scenario
  5. Global Filgrastim Biosimilars Market Size and Growth

.

.

.

  1. Global Filgrastim Biosimilars Market Competitive Benchmarking
  2. Global Filgrastim Biosimilars Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market
  4. Filgrastim Biosimilars Market Future Outlook and Potential Analysis
  5. Appendix

Top Major Players:

  • Teva Pharmaceutical Industries Ltd
  • Biocon Limited
  • Intas Biopharmaceuticals
  • Reddy’s Laboratories
  • Pfizer, Cadila Healthcare Ltd.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info  

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Good PR News

Recent Posts

Medical Terminology Software Market Share, Growth Opportunities, Demand Factors Report To 2033

The medical terminology software global market report 2024 from The Business Research Company provides comprehensive…

11 hours ago

Apples Market Expansion 2024-2033: Growth Drivers and Dynamics

The apples global market report 2024 from The Business Research Company provides comprehensive market statistics,…

11 hours ago

IP Video Surveillance And VSaaS Market Growth Analysis, Latest Trends And Business Opportunity 2024 To 2033

The ip video surveillance and vsaas global market report 2024 from The Business Research Company…

11 hours ago

Change And Configuration Management Market Expansion 2024-2033: Growth Drivers and Dynamics

The change and configuration management global market report 2024 from The Business Research Company provides…

11 hours ago

Generative AI In Gaming Market Share Analysis, Leading Players, Growth, Trends, And Forecast To 2033

The generative ai in gaming global market report 2024 from The Business Research Company provides…

11 hours ago

Electric Blankets Market Size, Emerging Trends, Market Opportunities, Key Players And Forecast To 2033

The electric blankets global market report 2024 from The Business Research Company provides comprehensive market…

12 hours ago